Detalhe da pesquisa
1.
Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank.
Am J Hum Genet
; 110(4): 648-662, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977412
2.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
3.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571512
4.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
5.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897700
6.
Genetic testing for hereditary breast cancer in Poland: 1998-2022.
Hered Cancer Clin Pract
; 21(1): 9, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312208
7.
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Br J Cancer
; 127(1): 84-91, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256754
8.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
9.
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.
J Med Genet
; 58(5): 305-313, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546565
10.
Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland.
Hered Cancer Clin Pract
; 20(1): 12, 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382848
11.
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Hered Cancer Clin Pract
; 20(1): 11, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313928
12.
PALB2 mutations and prostate cancer risk and survival.
Br J Cancer
; 125(4): 569-575, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006922
13.
Survival from breast cancer in women with a BRCA2 mutation by treatment.
Br J Cancer
; 124(9): 1524-1532, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597716
14.
Genetic predisposition to male breast cancer in Poland.
BMC Cancer
; 21(1): 975, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461861
15.
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update.
Hered Cancer Clin Pract
; 19(1): 13, 2021 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478551
16.
Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
Int J Cancer
; 147(10): 2793-2800, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32875559
17.
Blood arsenic levels and the risk of familial breast cancer in Poland.
Int J Cancer
; 146(10): 2721-2727, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348523
18.
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
Int J Cancer
; 146(5): 1293-1298, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469414
19.
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 159(3): 820-826, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010967
20.
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers.
Int J Gynecol Cancer
; 30(6): 825-830, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354794